Advanced search×

Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

R Hachamovitch, A Rozanski, L J Shaw, G W Stone, L E J Thomson, J D Friedman, S W Hayes, I Cohen, G Germano, and D S Berman

Eur Heart J 32(8):1012-24 (2011) PMID 21258084

Although pre-revascularization ischaemia testing is recommended, the interaction between the extent of ischaemia and myocardial scar with performance of revascularization on patient survival is unclear.

DOI: 10.1093/eurheartj/ehq500
Version: za2963e q8za3 q8zb9 q8zc8 q8zd0 q8zef q8zff q8zg6

Similar articles you may find interesting…

  1. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteris...
    Michel M Romanens, Franz F Ackermann, ... Michael M Pencina

    Eur J Cardiovasc Prev Rehabil 17(1):18-23 (2010) PMID 19952758

  2. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials.
    Francesco F Burzotta, Maria M De Vita, ... Felix F Zijlstra

    Eur Heart J 30(18):2193-203 (2009) PMID 19726437

    Individual data of 2686 patients enrolled in 11 trials entered the pooled analysis. Primary endpoint of the study was all-cause mortality. Major adverse cardiac events (MACE) were considered as the occurrence of all-cause death and/or target lesion/vessel revascularization and/or myocardial infarcti...
  3. The significance of transient ischemic dilation in the setting of otherwise normal SPECT radionuclide myocardial perfusion images.
    Carolina Valdiviezo, Apurva A Motivala, ... Mark I Travin

    J Nucl Cardiol 18(2):220-9 (2011) PMID 21327596

    TID in patients with an otherwise normal SPECT MPI study does not increase the likelihood of CAD, its extent or severity, and is not associated with worsened patient survival....